168 related articles for article (PubMed ID: 21628922)
41. Microemulsion system for topical delivery of thai mango seed kernel extract: development, physicochemical characterisation and ex vivo skin permeation studies.
Leanpolchareanchai J; Padois K; Falson F; Bavovada R; Pithayanukul P
Molecules; 2014 Oct; 19(11):17107-29. PubMed ID: 25347456
[TBL] [Abstract][Full Text] [Related]
42. Oil-in-water microemulsions enhance the biodegradation of DDT by Phanerochaete chrysosporium.
Zheng G; Selvam A; Wong JW
Bioresour Technol; 2012 Dec; 126():397-403. PubMed ID: 22520221
[TBL] [Abstract][Full Text] [Related]
43. Antiproliferative Ability and Fluorescence Tracking of α-Linolenic Acid-Loaded Microemulsion as Label-Free Delivery Carriers in MDA-MB-231 Cells.
Li Q; Liu X; Wang X; Qiu S; Byambasuren K; Dang L; Wang Z
J Agric Food Chem; 2019 Oct; 67(41):11518-11526. PubMed ID: 31513385
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of a new solid non-aqueous self-double-emulsifying drug-delivery system for topical application of quercetin.
Wang Q; Hu C; Zhang H; Zhang Y; Liu T; Qian A; Xia Q
J Microencapsul; 2016 Dec; 33(8):785-794. PubMed ID: 27875065
[TBL] [Abstract][Full Text] [Related]
45. Microemulsions for topical delivery of 8-methoxsalen.
Baroli B; López-Quintela MA; Delgado-Charro MB; Fadda AM; Blanco-Méndez J
J Control Release; 2000 Oct; 69(1):209-18. PubMed ID: 11018558
[TBL] [Abstract][Full Text] [Related]
46. A novel ionic liquid-in-oil microemulsion composed of biologically acceptable components: an excitation wavelength dependent fluorescence resonance energy transfer study.
Mandal S; Ghosh S; Banerjee C; Kuchlyan J; Banik D; Sarkar N
J Phys Chem B; 2013 Mar; 117(11):3221-31. PubMed ID: 23445434
[TBL] [Abstract][Full Text] [Related]
47. Preparation and evaluation of microemulsion formulations of naproxen for dermal delivery.
Ustündağ Okur N; Yavaşoğlu A; Karasulu HY
Chem Pharm Bull (Tokyo); 2014; 62(2):135-43. PubMed ID: 24492583
[TBL] [Abstract][Full Text] [Related]
48. Phase-transition W/O Microemulsions for Ocular Delivery: Evaluation of Antibacterial Activity in the Treatment of Bacterial Keratitis.
Bharti SK; Kesavan K
Ocul Immunol Inflamm; 2017 Aug; 25(4):463-474. PubMed ID: 26943481
[TBL] [Abstract][Full Text] [Related]
49. Investigation of microemulsion microstructures and their relationship to transdermal permeation of model drugs: ketoprofen, lidocaine, and caffeine.
Zhang J; Michniak-Kohn B
Int J Pharm; 2011 Dec; 421(1):34-44. PubMed ID: 21959104
[TBL] [Abstract][Full Text] [Related]
50. Microemulsions as a surrogate carrier for dermal drug delivery.
Azeem A; Khan ZI; Aqil M; Ahmad FJ; Khar RK; Talegaonkar S
Drug Dev Ind Pharm; 2009 May; 35(5):525-47. PubMed ID: 19016057
[TBL] [Abstract][Full Text] [Related]
51. Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme.
Cheng MB; Wang JC; Li YH; Liu XY; Zhang X; Chen DW; Zhou SF; Zhang Q
J Control Release; 2008 Jul; 129(1):41-8. PubMed ID: 18474405
[TBL] [Abstract][Full Text] [Related]
52. Microemulsion based gel for topical dermal delivery of pseudolaric acid B: In vitro and in vivo evaluation.
Wan T; Xu T; Pan J; Qin M; Pan W; Zhang G; Wu Z; Wu C; Xu Y
Int J Pharm; 2015 Sep; 493(1-2):111-20. PubMed ID: 26216411
[TBL] [Abstract][Full Text] [Related]
53. Oil-frozen W₁/O/W₂ double emulsions for dermal biomacromolecular delivery containing ethanol as chemical penetration enhancer.
Jaimes-Lizcano YA; Lawson LB; Papadopoulos KD
J Pharm Sci; 2011 Apr; 100(4):1398-406. PubMed ID: 20960570
[TBL] [Abstract][Full Text] [Related]
54. Microstructure, morphology, and ultrafast dynamics of a novel edible microemulsion.
Saha R; Rakshit S; Mitra RK; Pal SK
Langmuir; 2012 Jun; 28(22):8309-17. PubMed ID: 22571238
[TBL] [Abstract][Full Text] [Related]
55. Adapalene microemulsion for transfollicular drug delivery.
Bhatia G; Zhou Y; Banga AK
J Pharm Sci; 2013 Aug; 102(8):2622-31. PubMed ID: 23728912
[TBL] [Abstract][Full Text] [Related]
56. Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies.
Kantarci G; Ozgüney I; Karasulu HY; Arzik S; Güneri T
AAPS PharmSciTech; 2007 Nov; 8(4):E91. PubMed ID: 18181551
[TBL] [Abstract][Full Text] [Related]
57. Enhanced acyclovir delivery using w/o type microemulsion: preclinical assessment of antiviral activity using murine model of zosteriform cutaneous HSV-1 infection.
Kaur A; Sharma G; Gupta V; Ratho RK; Katare OP
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):346-354. PubMed ID: 28403666
[TBL] [Abstract][Full Text] [Related]
58. Novel dithranol phospholipid microemulsion for topical application: development, characterization and percutaneous absorption studies.
Raza K; Negi P; Takyar S; Shukla A; Amarji B; Katare OP
J Microencapsul; 2011; 28(3):190-9. PubMed ID: 21395406
[TBL] [Abstract][Full Text] [Related]
59. In vitro permeation and in vivo whitening effect of topical hesperetin microemulsion delivery system.
Tsai YH; Lee KF; Huang YB; Huang CT; Wu PC
Int J Pharm; 2010 Mar; 388(1-2):257-62. PubMed ID: 20060453
[TBL] [Abstract][Full Text] [Related]
60. Microemulsion-based hydrogel formulation of ibuprofen for topical delivery.
Chen H; Chang X; Du D; Li J; Xu H; Yang X
Int J Pharm; 2006 Jun; 315(1-2):52-8. PubMed ID: 16600540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
